IBDEI0ZB ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15941,2)
 ;;=^5009283
 ;;^UTILITY(U,$J,358.3,15942,0)
 ;;=L73.0^^61^765^4
 ;;^UTILITY(U,$J,358.3,15942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15942,1,3,0)
 ;;=3^Acne Keloid
 ;;^UTILITY(U,$J,358.3,15942,1,4,0)
 ;;=4^L73.0
 ;;^UTILITY(U,$J,358.3,15942,2)
 ;;=^2149
 ;;^UTILITY(U,$J,358.3,15943,0)
 ;;=L73.2^^61^765^162
 ;;^UTILITY(U,$J,358.3,15943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15943,1,3,0)
 ;;=3^Hidradenitis Suppurativa
 ;;^UTILITY(U,$J,358.3,15943,1,4,0)
 ;;=4^L73.2
 ;;^UTILITY(U,$J,358.3,15943,2)
 ;;=^278979
 ;;^UTILITY(U,$J,358.3,15944,0)
 ;;=L73.9^^61^765^156
 ;;^UTILITY(U,$J,358.3,15944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15944,1,3,0)
 ;;=3^Follicular Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,15944,1,4,0)
 ;;=4^L73.9
 ;;^UTILITY(U,$J,358.3,15944,2)
 ;;=^5009286
 ;;^UTILITY(U,$J,358.3,15945,0)
 ;;=L82.0^^61^765^163
 ;;^UTILITY(U,$J,358.3,15945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15945,1,3,0)
 ;;=3^Inflamed Seborrheic Keratosis
 ;;^UTILITY(U,$J,358.3,15945,1,4,0)
 ;;=4^L82.0
 ;;^UTILITY(U,$J,358.3,15945,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,15946,0)
 ;;=L82.1^^61^765^304
 ;;^UTILITY(U,$J,358.3,15946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15946,1,3,0)
 ;;=3^Seborrheic Keratosis NEC
 ;;^UTILITY(U,$J,358.3,15946,1,4,0)
 ;;=4^L82.1
 ;;^UTILITY(U,$J,358.3,15946,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,15947,0)
 ;;=L84.^^61^765^118
 ;;^UTILITY(U,$J,358.3,15947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15947,1,3,0)
 ;;=3^Corns and Callosities
 ;;^UTILITY(U,$J,358.3,15947,1,4,0)
 ;;=4^L84.
 ;;^UTILITY(U,$J,358.3,15947,2)
 ;;=^271920
 ;;^UTILITY(U,$J,358.3,15948,0)
 ;;=L85.0^^61^765^9
 ;;^UTILITY(U,$J,358.3,15948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15948,1,3,0)
 ;;=3^Acquired Ichthyosis
 ;;^UTILITY(U,$J,358.3,15948,1,4,0)
 ;;=4^L85.0
 ;;^UTILITY(U,$J,358.3,15948,2)
 ;;=^5009320
 ;;^UTILITY(U,$J,358.3,15949,0)
 ;;=L85.1^^61^765^11
 ;;^UTILITY(U,$J,358.3,15949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15949,1,3,0)
 ;;=3^Acquired Keratosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,15949,1,4,0)
 ;;=4^L85.1
 ;;^UTILITY(U,$J,358.3,15949,2)
 ;;=^5009321
 ;;^UTILITY(U,$J,358.3,15950,0)
 ;;=L85.2^^61^765^169
 ;;^UTILITY(U,$J,358.3,15950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15950,1,3,0)
 ;;=3^Keratosis Punctata
 ;;^UTILITY(U,$J,358.3,15950,1,4,0)
 ;;=4^L85.2
 ;;^UTILITY(U,$J,358.3,15950,2)
 ;;=^5009322
 ;;^UTILITY(U,$J,358.3,15951,0)
 ;;=L85.3^^61^765^329
 ;;^UTILITY(U,$J,358.3,15951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15951,1,3,0)
 ;;=3^Xerosis Cutis
 ;;^UTILITY(U,$J,358.3,15951,1,4,0)
 ;;=4^L85.3
 ;;^UTILITY(U,$J,358.3,15951,2)
 ;;=^5009323
 ;;^UTILITY(U,$J,358.3,15952,0)
 ;;=L86.^^61^765^167
 ;;^UTILITY(U,$J,358.3,15952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15952,1,3,0)
 ;;=3^Keratoderma in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,15952,1,4,0)
 ;;=4^L86.
 ;;^UTILITY(U,$J,358.3,15952,2)
 ;;=^5009326
 ;;^UTILITY(U,$J,358.3,15953,0)
 ;;=L87.0^^61^765^168
 ;;^UTILITY(U,$J,358.3,15953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15953,1,3,0)
 ;;=3^Keratosis Follicularis et Parafollicularis in Cutem Penetrans
 ;;^UTILITY(U,$J,358.3,15953,1,4,0)
 ;;=4^L87.0
 ;;^UTILITY(U,$J,358.3,15953,2)
 ;;=^5009327
 ;;^UTILITY(U,$J,358.3,15954,0)
 ;;=L87.2^^61^765^144
 ;;^UTILITY(U,$J,358.3,15954,1,0)
 ;;=^358.31IA^4^2
